1421621-12-6 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 4-bromo-2-chloronicotinate is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new compounds with potential therapeutic applications.
Used in Agrochemical Industry:
Ethyl 4-bromo-2-chloronicotinate is used as an intermediate in the synthesis of agrochemicals, aiding in the creation of new compounds with potential agricultural applications.
Used in Organic Synthesis:
Ethyl 4-bromo-2-chloronicotinate is used as a building block in organic synthesis, enabling the formation of various functional materials and compounds.
Used in Research and Development:
Ethyl 4-bromo-2-chloronicotinate is used in the research and development of new compounds, leveraging its versatility to explore its potential in creating therapeutic or agricultural solutions.
Proper handling and safety precautions should be observed when working with Ethyl 4-bromo-2-chloronicotinate to ensure the safety of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 1421621-12-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,1,6,2 and 1 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1421621-12:
(9*1)+(8*4)+(7*2)+(6*1)+(5*6)+(4*2)+(3*1)+(2*1)+(1*2)=106
106 % 10 = 6
So 1421621-12-6 is a valid CAS Registry Number.
1421621-12-6Relevant articles and documents
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
-
Page/Page column, (2014/06/24)
The invention relates to heterocyclic amide derivatives of formula (I), wherein R1, R2, R3, R4, R5, X, Y and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
-
Page/Page column 78, (2013/03/26)
The invention relates to heterocyclic amide derivatives of formula (I), wherein R1, R2, R3, R4, R5, X, Y and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.
